The WHO Pandemic Agreement Solved a Negotiation Problem. It Didn't Solve an Implementation Problem.
Adopting a global pandemic agreement was a genuine diplomatic achievement. Turning its provisions into functioning national systems is a different kind of work entirely, and it's where most of the value will be won or lost.
The adoption of a global pandemic agreement was, by any reasonable measure, a significant diplomatic accomplishment. Negotiating shared terms on pathogen access, benefit sharing, and pandemic response coordination across countries with sharply different resources and interests took years of sustained effort. But an agreement is a floor, not an outcome. The gap between what the agreement commits countries to and what actually functions on the ground during the next health emergency is where most of the real work, and most of the real risk, now sits.
Agreements don't build laboratories
Provisions around equitable access to pandemic countermeasures and shared pathogen data depend on national systems that many countries are still building: functioning genomic surveillance networks, regulatory capacity to authorize and distribute countermeasures quickly, and health workforce capacity to actually deliver them at scale. A commitment on paper to equitable access doesn't create the cold chain infrastructure or the trained personnel needed to make it real.
This is a familiar pattern in global health governance. International agreements tend to be strongest exactly where enforcement is weakest, at the level of implementation within individual countries with vastly different starting capacity. The countries that will benefit most from this agreement in a future pandemic are the ones investing now in the underlying systems the agreement assumes already exist.
Technical assistance is not the same as implementation partnership
A great deal of international support for pandemic preparedness takes the form of technical assistance: guidance documents, training workshops, and short-term advisory missions. These have real value, but they rarely build the sustained institutional capacity required to operate complex systems independently over years, particularly in countries facing competing health priorities and constrained budgets.
Closing the implementation gap requires a different model: longer engagement horizons, embedded technical support that transfers capability rather than just delivering recommendations, and financing structures that don't disappear once the initial grant cycle ends. That model is harder to fund and harder to demonstrate quick results from, which is exactly why it's underinvested relative to its long-term value.
Where the next five years will be decided
The pandemic agreement's ultimate impact will be determined less by its text than by whether the implementation support behind it is structured to build lasting national capacity or simply to demonstrate short-term compliance. Countries, funders, and technical partners who treat the agreement as a starting point for sustained capacity building, rather than a finished achievement, are the ones positioning the world to actually be better prepared next time.